Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Tirzepatide: Dual GIP/GLP-1 Receptor Agonism Tirzepatide (LY3298176) is a synthetic 39-amino-acid peptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R), with a C20 fatty diacid moiety for albumin binding
Clinical trials of compound 28 (Figure 5) suggested its potential as an effective option for biweekly therapy (103)
The swelling of mitochondria, the dilatation of intercellular space and the dilatation of inner plasma can be seen clearly in electron microscope (1012)
Diabetes/Metabolic disorders
For example, arginine and glutamine are involved in energy metabolism and protein turnover, which are critical for maintaining growth during stress
Animal studies show that increased growth hormone levels from ipamorelin treatment can produce decreases of approximately 14% in fat mass without dietary modifications
